Figure 1.
Survival probability graph showing the lengths of time in which eyes in the bevacizumab monotherapy and combined groups remained without requiring retreatments.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.